MorphoSys AG (MOR)
NASDAQ: MOR
· Real-Time Price · USD
18.96
0.45 (2.43%)
At close: Aug 02, 2024, 10:00 PM
MorphoSys Income Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 203.58M | 238.36M | 260.95M | 292.85M | 299.13M | 278.31M | 249.54M | 195.09M | 173.84M | 179.53M | 162.68M | 143.43M | 123.67M |
Cost of Revenue | 41.22M | 58.34M | 59.21M | 52.21M | 61.75M | 48.66M | 42.74M | 42.12M | 34.98M | 32.13M | 32.05M | 28.29M | 25.42M |
Gross Profit | 162.36M | 180.02M | 201.74M | 240.64M | 237.38M | 229.65M | 206.8M | 152.96M | 138.86M | 147.4M | 130.63M | 115.14M | 98.25M |
Operating Income | -447.34M | -252.42M | -211.73M | -190.63M | -195.2M | -193.6M | -477.91M | -530.37M | -546.66M | -507.36M | -257.53M | -237.2M | -214.16M |
Interest Income | 92.63M | 147.57M | 227.03M | 296.07M | 295.65M | 251.25M | 137.06M | 66.76M | 165.88M | 169.18M | 127.73M | 160.12M | 72.29M |
Pretax Income | -455.94M | -189.21M | 266.33M | 262.43M | 95.58M | 17.51M | -899.71M | -930.72M | -657.31M | -589.91M | -211.42M | -154.63M | -247.02M |
Net Income | -460.26M | -189.19M | 91.99M | 88.69M | -72.34M | -213.77M | -924.21M | -914.08M | -658.19M | -513.48M | -149.01M | -101.58M | -175.57M |
Selling & General & Admin | 267.68M | 92.5M | 79.89M | 84.09M | 81.48M | 90.21M | 162.69M | 175.34M | 197.95M | 199.87M | 196.14M | 190.52M | 174.62M |
Research & Development | 285.67M | 283.59M | 297.29M | 311.89M | 315.8M | 297.73M | 290.72M | 277.29M | 256.87M | 224.19M | 192.01M | 161.81M | 152.25M |
Other Expenses | -762.15K | -486.9K | 62.67M | 62.67M | 62.6M | 62.32M | n/a | 757.45K | 1.06M | 1.06M | 1.77M | 1.37M | -634.59K |
Operating Expenses | 607.98M | 430.72M | 439.5M | 458.3M | 459.6M | 450.26M | 453.41M | 452.63M | 454.82M | 424.06M | 388.16M | 352.34M | 326.87M |
Interest Expense | 98.26M | 123.68M | 123.68M | 224.08M | 380.91M | 415.45M | 415.45M | 320.62M | 240.81M | 217.7M | 217.7M | 212.6M | 132.34M |
Selling & Marketing Expenses | 7.89M | 6.32M | -4.27M | -669.25K | 1.31M | 6.33M | 101.9M | 110.78M | 115.27M | 121.54M | 121.81M | 122.3M | 123.08M |
Cost & Expenses | 649.21M | 489.06M | 498.71M | 510.51M | 521.35M | 498.93M | 496.15M | 494.75M | 489.8M | 456.19M | 420.2M | 380.63M | 337.83M |
Income Tax Expense | 27.43M | 28.47M | 202.84M | 202.24M | 168.01M | 231.37M | 24.29M | -16.84M | 682.86K | -76.62M | -62.41M | -53.05M | -71.45M |
Shares Outstanding (Basic) | 150.47M | 158.41M | 136.68M | 136.67M | 136.66M | 136.66M | 136.62M | 136.6M | 136.6M | 136.56M | 136.53M | 137.01M | 131.04M |
Shares Outstanding (Diluted) | 150.47M | 158.36M | 136.68M | 136.67M | 136.66M | 136.66M | 136.62M | 136.6M | 136.6M | 136.56M | 136.53M | 141.48M | 131.04M |
EPS (Basic) | -3.16 | -1.33 | 0.76 | 0.74 | -0.44 | -1.11 | -6.31 | -6.23 | -4.35 | -3.77 | -1.11 | -0.78 | -1.35 |
EPS (Diluted) | -3.18 | -1.34 | 0.76 | 0.74 | -0.44 | -1.11 | -6.31 | -6.23 | -4.36 | -3.78 | -1.11 | -0.79 | -1.35 |
EBITDA | -327.75M | -78.33M | 125.71M | 220.01M | 210.57M | 164.92M | -158.64M | -281.45M | -302.7M | -256.29M | -203.81M | -152.3M | -111.45M |
EBIT | -357.39M | -51.85M | 101.07M | 199.23M | 191.01M | 134.04M | -392.74M | -518.6M | -325.04M | -281.69M | -2.81M | 48.88M | -123.73M |
Depreciation & Amortization | 8.82M | 10.54M | 11.04M | 11.01M | 10.6M | 10.41M | 10.58M | 10.58M | 10.35M | 10.09M | 10.1M | 9.29M | 8.8M |